Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)

Circulation Journal - Tập 77 Số 9 - Trang 2341-2348 - 2013
Hisao Ogawa1, Shinya Goto2, Masunori Matsuzaki3, Shintaro Hiro4, Daisuke Shima5, On Behalf Of The FIDELIO-DKD Study Investigators
1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
2Department of Medicine (Cardiology), Tokai University School of Medical
3Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine
4Clinical Statistics, Pfizer Japan Inc
5Cardiovascular and Metabolism Therapeutics, Pfizer Japan Inc

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Circulation Journal

Tập 77 Số 9

2341-2348

Thông tin tác giả